Millipore Sigma Vibrant Logo

MAC129 Anti-Llama IgG Antibody, clone P17IG12

Anti-Llama IgG Antibody, clone P17IG12 is an antibody against Llama IgG for use in ELISA.

Anti-Llama IgG Antibody, clone P17IG12 MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Research Category: Secondary & Control Antibodies Research Sub-Category: Secondary Antibodies Adsorbed for Dual Labeling
MAC129
100 µg  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Fulfillment and Delivery Delayed Fulfillment and Delivery Delayed
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Special Offers

       

      Contact Customer Service

      Overview

      Replacement Information

      Special Offers

      100% Performance Guaranteed

      Key Spec Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      CamelidELISAMPurifiedMonoclonal Antibody
      Description
      Catalogue NumberMAC129
      DescriptionAnti-Llama IgG Antibody, clone P17IG12
      Alternate Names
      • Llama IgG
      Background InformationClone P17IG12 is a mouse monoclonal with immunoreactivity toward llama IgG1, IgG2, and IgG3. Species reactivity testing by ELISA shows less immunoreactivity against guinea pig IgG and much reduced or little cross-reactivity toward human, rabbit, goat, sheep, and chicken IgG.
      References
      Product Information
      FormatPurified
      PresentationPurified mouse monoclonal IgG2aκ in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
      Quality LevelMQ300
      Applications
      ApplicationAnti-Llama IgG Antibody, clone P17IG12 is an antibody against Llama IgG for use in ELISA.
      Key Applications
      • ELISA
      Biological Information
      ImmunogenPolyclonal Camelid IgG2a (long-hinge hcAb corresponding to Camelid (total).
      CloneP17IG12
      ConcentrationPlease refer to lot specific datasheet.
      HostMouse
      IsotypeIgG2aκ
      Species Reactivity
      • Camelid
      Antibody TypeMonoclonal Antibody
      Purification MethodProtein G Purified
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by ELISA in HeLa cell lysate.

      ELISA Analysis: 1.0 µg/mL of this antibody detected Llama IgG1, llama IgG2, and llama IgG3 in ELISA.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      MAC129 04055977161595

      Documentation

      Anti-Llama IgG Antibody, clone P17IG12 Certificates of Analysis

      TitleLot Number
      Anti-Llama IgG, clone P17IG12 - 3041603 3041603
      Anti-Llama IgG, clone P17IG12 - 3228357 3228357
      Anti-Llama IgG, clone P17IG12 - 3380951 3380951
      Anti-Llama IgG, clone P17IG12 - 3488904 3488904
      Anti-Llama IgG, clone P17IG12 - 3980270 3980270
      Anti-Llama IgG, clone P17IG12 -Q2559157 Q2559157
      Anti-Llama IgG, clone P17IG12 Monoclonal Antibody 2981022

      Technical Info

      Title
      White Paper: Further considerations of antibody validation and usage.